IRadimed Corporation
Rating
Updated: Sep 11, 2026Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
IRADIMED CORPORATION specializes in the engineering, production, and distribution of medical devices specifically designed for compatibility with magnetic resonance imaging (MRI) environments. The com...
Latest News
6 days ago · defenseworld.net
Head-To-Head Contrast: iRadimed (NASDAQ:IRMD) & Medline (NASDAQ:MDLN)iRadimed (NASDAQ: IRMD - Get Free Report) and Medline (NASDAQ: MDLN - Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, profitability, institutional ownership, valuation and earnings. Insider and Institutional Ownership 92.3% of iRadimed shares are owned
18 days ago · gurufocus.com
iRadimed Corp (IRMD) Stock Down 3.8% but Still Overvalued -- GF Score: 92/100On September 04, 2026, iRadimed Corp (IRMD) shares fell 3.8%, currently trading at $83.45. The stock has seen a notable decline, with a 52-week high of $107.90
2 months ago · marketbeat.com
iRadimed Q2 Earnings Call HighlightsiRadimed NASDAQ: IRMD reported second-quarter 2026 revenue of $20.5 million, up 0.5% from a year earlier, as the company began general-release production of its new 3870 MRI IV pump system and worked through the costs associated with an initial manufacturing ramp.
2 months ago · seekingalpha.com
IRADIMED CORPORATION (IRMD) Q2 2026 Earnings Call TranscriptIRADIMED CORPORATION (IRMD) Q2 2026 Earnings Call Transcript
2 months ago · globenewswire.com
IRADIMED CORPORATION Reports Second Quarter 2026 Financial ResultsAnnounces Regular Quarterly Cash Dividend of $0.20 Per Share Reaffirms Full-Year 2026 Revenue and Earnings Guidance Reports revenue of $20.5 million for the second quarter of 2026, which increased by $0.1 million, or 0.5% compared to the same period in 2025. Reports GAAP diluted EPS of $0.41 and non-GAAP diluted EPS of $0.46 for the second quarter of 2026.
2 months ago · globenewswire.com
IRADIMED CORPORATION to Hold Second Quarter 2026 Financial Results Conference Call on July 31, 2026ORLANDO, Fla., July 24, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2026 second quarter financial results before the market opens on Friday, July 31, 2026. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions.
4 months ago · fool.com
IRADIMED's CEO Is Selling Steadily — The Plan, Not the Stock, Is Driving ItThis medical device maker, known for MRI-compatible equipment, reported a notable insider sale amid strong one-year stock performance.
5 months ago · gurufocus.com
iRadimed Corp (IRMD) Shares Surge 4.4% -- What GF Score of 95 Tells InvestorsOn May 01, 2026, iRadimed Corp (IRMD) shares rose 4.4%, bringing the current price to $87.15. This movement comes amid a 52-week range that has seen a high of $
5 months ago · seekingalpha.com
IRADIMED CORPORATION (IRMD) Q1 2026 Earnings Call TranscriptIRADIMED CORPORATION (IRMD) Q1 2026 Earnings Call Transcript
5 months ago · zacks.com
iRadimed (IRMD) Beats Q1 Earnings and Revenue EstimatesiRadimed (IRMD) came out with quarterly earnings of $0.49 per share, beating the Zacks Consensus Estimate of $0.45 per share. This compares to earnings of $0.42 per share a year ago.
Add to Watchlist
Select watchlists to add or remove IRMD